Top Markets
#1 Black Phoenix Black Phoenix +829.08%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.93%
#3 Beam Beam +23.05%
#4 SAFEcoin SAFEcoin +20.65%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +19.20%
#6 Magma Finance Magma Finance +16.99%
#7 Prom Prom +16.39%
#8 Bless Bless +16.28%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +16.00%
#10 THORChain THORChain +15.86%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
株式のランク #5958
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
株価
$18.55
時価総額
$2.40B
変化（1日）
0.60%
変化（1年）
-
国
US
取引 Kailera Therapeutics, Inc. (KLRA)

カテゴリー

Healthcare
Kailera Therapeutics, Inc.（KLRA）のEPS
2026 時点のEPS TTM: 0
Kailera Therapeutics, Inc.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Kailera Therapeutics, Inc.のEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH